For laboratory research use only. Not for human consumption, veterinary use, or household use.

Retatrutide is a synthetic research peptide supplied as a lyophilized powder. It is intended for qualified laboratories conducting in-vitro, analytical, or other non-clinical work on peptide structure, identity, and assay methods.

This material is a research chemical. It is not a medicine, compounded drug, supplement, or weight-management product.

Intended research use

• Reference material for identity and purity testing
• Peptide assay and method-development work
• Controlled laboratory comparison of research peptides
• Analytical and documentation studies in institutional lab settings

Product details

• Name: Retatrutide (Reta)
• Type: Synthetic research peptide
• Form: Lyophilized powder
• Brand: Evo Peptides
• Use: Laboratory research only

Handle under your institution’s chemical-hygiene rules. Use appropriate PPE. Store lyophilized material as directed on the label and any batch documents.

A certificate of analysis is available for batch identity and purity verification where issued.

Compliance notice
Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease. Not for compounding, clinical, or consumer use. Purchasers are responsible for following applicable research and institutional rules.

For Research Use Only.

Current Research:

• Triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors to support appetite regulation and metabolism.
• Clinical trials showed average weight loss in research participants of up to 24.2% over 48 weeks in adults with obesity.
• Research also found improvements in blood sugar, waist circumference, blood pressure, and other metabolic health markers.
• Participants were still losing weight at the end of the 48-week study, suggesting continued potential benefits.

References: